ITMCTR2000004143尚未招募1 期
A randomized, double-blind, placebo-controlled multicenter clinical study of Xifeng Huashi Granules in the treatment of diarrheal irritable bowel syndrome
Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •1. In line with the diagnostic criteria of WESTERN medicine IBS-D;
- •2. In line with the standard of TCM syndrome diagnosis of liver depression and spleen deficiency;
- •3. Aged 18-70 (including 18 and 70 years old) years;
- •4. Informed consent, voluntary test. The process of obtaining informed consent should comply with ethical principles.
排除标准
- •1. Patients with organic gastrointestinal diseases;
- •2. Patients with severe heart, liver, kidney, respiratory, blood and endocrine diseases;
- •3. Patients with mental illness and severe neurosis;
- •4. Women who are pregnant, breastfeeding or planning to have a pregnancy;
- •5. Those who had taken antibiotics or probiotics or gastrointestinal motility drugs within 1 month before the included test;
- •6. Poor compliance with medical advice, patients allergic to this drug;
- •7. Patients who are participating in other clinical studies.
研究者
相似试验
进行中（未招募）
1 期
Study of efficacy and safety of secukinumab in Psoriatic Arthritis and axial Spondyloarthritis patients withactive enthesitis including one Achilles tendon site (ACHILLES)Psoriatic arthritisAxial spondyloarthritisMedDRA version: 21.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 21.1Level: PTClassification code 10071400Term: Axial spondyloarthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2016-000972-91-GBovartis Pharma Services AG204
进行中（未招募）
1 期
Study of efficacy and safety of secukinumab in patients with non-radiographic axial spondyloarthritis.on-radiographic axial spondyloarthritisMedDRA version: 20.0Level: LLTClassification code 10076297Term: Non-radiographic axial spondyloarthritisSystem Organ Class: 100000004859EUCTR2015-001106-33-ITOVARTIS PHARMA SERVICES AG555
进行中（未招募）
1 期
Study of efficacy and safety of secukinumab in patients with non-radiographic axial spondyloarthritisEUCTR2015-001106-33-ESovartis Farmacéutica S.A.555
进行中（未招募）
1 期
Study of safety and efficacy of ianalumab in patients with primary Sjogren’s Syndrome (pSS)Primary Sjogren’s syndromeMedDRA version: 21.0Level: PTClassification code 10040767Term: Sjogren's syndromeSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2016-003292-22-DEovartis Pharma AG180
进行中（未招募）
1 期
Study of efficacy and safety of secukinumab in Psoriatic Arthritis and axial Spondyloarthritis patients with active enthesitis including one Achilles tendon site (ACHILLES)Psoriatic arthritis Axial spondyloarthritisMedDRA version: 19.0 Level: LLT Classification code 10037160 Term: Psoriatic arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 19.0 Level: PT Classification code 10071400 Term: Axial spondyloarthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2016-000972-91-SKovartis Pharma Services AG200